Tyramine reveals failing α2-Adrenoceptor control of catecholamine release and total peripheral vascular resistance in hypertensive rats

Frontiers in Neurology

Volumn 4 FEB, Issue , 2013, Pages

  Berg, Torill ^a   Jensen, Jørgen ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

Author keywords

Epinephrine; Hypertension; Norepinephrine; Release control; Sympathetic nervous system; Total peripheral vascular resistance

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ATROPINE; CATECHOLAMINE; CLONIDINE; N [2 (1,3,4,6,7,12B HEXAHYDRO 2' OXOSPIRO[2H BENZOFURO[2,3 A]QUINOLIZINE 2,4' IMIDAZOLIDIN] 3' YL)ETHYL]METHANESULFONAMIDE; NORADRENALIN TRANSPORTER; TYRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HEART OUTPUT; HYPERTENSION; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PRESYNAPTIC NERVE; PROTEIN FUNCTION; RAT; SURGICAL STRESS; VASCULAR RESISTANCE;

EID: 84878812710     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00019     Document Type: Article

References (33)

1. Berg, T. (2002). Analysis of the pressor response to the K+ channel inhibitor 4-aminopyridine. Eur. J. Pharmacol. 452, 325-337.
2. Berg, T. (2003). The vascular response to the K+ channel inhibitor 4-aminopyridine in hypertensive rats. Eur. J. Pharmacol. 466, 301-310.
3. Berg, T. (2005). Increased counteracting effect of eNOS and nNOS on an alpha(1)-adrenergic rise in total peripheral vascular resistance in spontaneous hypertensive rats. Cardiovasc. Res. 67, 736-744.
4. Berg, T., Degerman, E., and Tasken, K. (2009). Increased cAMP signaling can ameliorate the hypertensive condition in spontaneously hypertensive rats. J. Vasc. Res. 46, 25-35.
5. Berg, T., and Jensen, J. (2011). Simultaneous parasympathetic and sympathetic activation reveals altered autonomic control of heart rate, vascular tension, and epinephrine release in anesthetized hypertensive rats. Front. Neurol. 2:71. doi:10.3389/fneur.2011.00071
6. Berg, T., Piercey, B. W., and Jensen, J. (2010). Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats. Hypertension 55, 1224-1230.
7. Berg, T., Walaas, S. I., Roberg, B. A., Huynh, T. T., and Jensen, J. (2012). Plasma norepinephrine in hypertensive rats reflects alpha(2)-adrenoceptor release control only when re-uptake is inhibited. Front. Neurol. 3:160. doi:10.3389/fneur.2012.00160
8. Burnstock, G., and Verkhratsky, A. (2010). Vas deferens - a model used to establish sympathetic cotransmission. Trends Pharmacol. Sci. 31, 131-139.
9. Carter, R. W., Begaye, M., and Kanagy, N. L. (2002). Acute and chronic NOS inhibition enhances alpha(2)-adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta. Am. J. Physiol. 283, H1361-H1369.
10. Clineschmidt, B. V., Pettibone, D. J., Lotti, V. J., Hucker, H. B., Sweeney, B. M., Reiss, D. R., et al. (1988). A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066. J. Pharmacol. Exp. Ther. 245, 32-40.
11. Crassous, P. A., Denis, C., Paris, H., and Senard, J. M. (2007). Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr. Top. Med. Chem. 7, 187-194.
12. Esler, M. (2010). The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J. Appl. Physiol. 108, 227-237.
13. Esler, M. D., Lambert, G. W., Ferrier, C., Kaye, D. M., Wallin, B. G., Kalff, V., et al. (1995). Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin. Exp. Hypertens. 17, 409-423.
14. Fagerholm, V., Haaparanta, M., and Scheinin, M. (2011). Alpha 2-adrenoceptor regulation of blood glucose homeostasis. Basic Clin. Pharmacol. Toxicol. 108, 365-370.
15. Feres, T., Borges, A. C., Silva, E. G., Paiva, A. C., and Paiva, T. B. (1998). Impaired function of alpha-2 adrenoceptors in smooth muscle of mesenteric arteries from spontaneously hypertensive rats. Br. J. Pharmacol. 125, 1144-1149.
16. Hunt, R. D., Arnsten, A. F., and Asbell, M. D. (1995). An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 34, 50-54.
17. Jensen, J., Ruzzin, J., Jebens, E., Brennesvik, E. O., and Knardahl, S. (2005). Improved insulin-stimulated glucose uptake and glycogen synthase activation in rat skeletal muscles after adrenaline infusion: role of glycogen content and PKB phosphorylation. Acta Physiol. Scand. 184, 121-130.
18. Kubista, H., and Boehm, S. (2006). Molecular mechanisms underlying the modulation of exocytotic noradrenaline release via presynaptic receptors. Pharmacol. Ther. 112, 213-242.
19. MacArthur, H., Wilken, G. H., Westfall, T. C., and Kolo, L. L. (2011). Neuronal and non-neuronal modulation of sympathetic neurovascular transmission. Acta Physiol. (Oxf.) 203, 37-45.
20. Majewski, H. (1983). Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors. J. Auton. Pharmacol. 3, 47-60.
21. Makaritsis, K. P., Johns, C., Gavras, I., Altman, J. D., Handy, D. E., Bresnahan, M. R., et al. (1999). Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype. Hypertension 34, 403-407.
22. Mandela, P., and Ordway, G. A. (2006). The norepinephrine transporter and its regulation. J. Neurochem. 97, 310-333.
23. Miralles, A., Asensio, V. J., and Garcia-Sevilla, J. A. (2002). Acute treatment with the cyclic antidepressant desipramine, but not fluoxetine, increases membrane-associated G protein-coupled receptor kinases 2/3 in rat brain. Neuropharmacology 43, 1249-1257.
24. Moura, E., Pinto, C. E., Calo, A., Serrao, M. P., Afonso, J., and Vieira-Coelho, M. A. (2011). alpha-Adrenoceptor-mediated inhibition of catecholamine release from the adrenal medulla of spontaneously hypertensive rats is preserved in the early stages of hypertension. Basic Clin. Pharmacol. Toxicol. 109, 253-260.
25. Oldendorf, W. H. (1971). Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am. J. Physiol. 221, 1629-1639.
26. Philipp, M., Brede, M., and Hein, L. (2002). Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am. J. Physiol. 283, R287-R295.
27. Reja, V., Goodchild, A. K., and Pilowsky, P. M. (2002). Catecholamine-related gene expression correlates with blood pressures in SHR. Hypertension 40, 342-347.
28. Remie, R., Van Rossum, J. X., Coppes, R. P., and Zaagsma, J. (1992). Dysfunctional presynaptic alpha 2-adrenoceptors expose facilitatory beta 2-adrenoceptors in the vasculature of spontaneously hypertensive rats. Eur. J. Pharmacol. 211, 257-261.
29. Shafaroudi, M. M., McBride, M., Deighan, C., Wokoma, A., MacMillan, J., Daly, C. J., et al. (2005). Two "knockout" mouse models demonstrate that aortic vasodilatation is mediated via alpha 2a-adrenoceptors located on the endothelium. J. Pharmacol. Exp. Ther. 314, 804-810.
30. Starke, K. (2001). Presynaptic autoreceptors in the third decade: focus on alpha 2-adrenoceptors. J. Neurochem. 78, 685-693.
31. Starke, K., Gothert, M., and Kilbinger, H. (1989). Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69, 864-989.
32. Yamada, S., Ashizawa, N., Nakayama, K., Tomita, T., and Hayashi, E. (1989). Decreased density of alpha 2-adrenoceptors in medulla oblongata of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 13, 440-446.
33. Zugck, C., Lossnitzer, D., Backs, J., Kristen, A., Kinscherf, R., and Haass, M. (2003). Increased cardiac norepinephrine release in spontaneously hypertensive rats: role of presynaptic alpha-2A adrenoceptors. J. Hypertens. 21, 1363-1369.